ATE336002T1 - Assays für tsh-rezeptor-autoantikörper - Google Patents

Assays für tsh-rezeptor-autoantikörper

Info

Publication number
ATE336002T1
ATE336002T1 AT99925202T AT99925202T ATE336002T1 AT E336002 T1 ATE336002 T1 AT E336002T1 AT 99925202 T AT99925202 T AT 99925202T AT 99925202 T AT99925202 T AT 99925202T AT E336002 T1 ATE336002 T1 AT E336002T1
Authority
AT
Austria
Prior art keywords
tsh receptor
body fluid
sample
trab
tsh
Prior art date
Application number
AT99925202T
Other languages
English (en)
Inventor
Jane Sanders
Bernard Rees Smith
Jadwiga Furmaniak
Original Assignee
Rsr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812146.0A external-priority patent/GB9812146D0/en
Application filed by Rsr Ltd filed Critical Rsr Ltd
Application granted granted Critical
Publication of ATE336002T1 publication Critical patent/ATE336002T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT99925202T 1998-06-06 1999-06-04 Assays für tsh-rezeptor-autoantikörper ATE336002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812146.0A GB9812146D0 (en) 1998-06-06 1998-06-06 Assays for TSH receptor autoantibodies
GBGB9909661.2A GB9909661D0 (en) 1998-06-06 1999-04-28 Assays for TSH receptor autoantibodies

Publications (1)

Publication Number Publication Date
ATE336002T1 true ATE336002T1 (de) 2006-09-15

Family

ID=26313803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99925202T ATE336002T1 (de) 1998-06-06 1999-06-04 Assays für tsh-rezeptor-autoantikörper

Country Status (8)

Country Link
US (1) US6844162B1 (de)
EP (1) EP1021721B1 (de)
JP (1) JP4331403B2 (de)
AT (1) ATE336002T1 (de)
DE (1) DE69932699T2 (de)
ES (1) ES2270601T3 (de)
GB (1) GB9909661D0 (de)
WO (1) WO1999064865A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035706C2 (de) * 2000-07-21 2002-11-07 Brahms Ag Verfahren zur selektiven Bestimmung von blockierenden Autoantikörpern gegen den TSH-Rezeptor
EP1456234B1 (de) * 2001-08-23 2014-04-09 Rsr Limited Epitop-regionen des thyrotrophin (tsh) rezeptors, verwendungen davon und antikörper dagegen
GB0227964D0 (en) * 2002-11-29 2003-01-08 Rsr Ltd Binding partners for the thyrotropin receptor and uses thereof
JP5314234B2 (ja) * 2002-11-29 2013-10-16 アールエスアール リミテッド チロトロピン受容体の結合対象及びその使用
EP1631589A1 (de) * 2003-06-04 2006-03-08 Université de Liège Immobilisierte membrane proteine und methoden für dessen anwendungen.
JP5405111B2 (ja) 2005-09-26 2014-02-05 ウルリヒ ルース Tsh受容体及び新規tsh受容体キメラに対する自己免疫抗体検出方法
CN101657468B (zh) * 2007-02-15 2014-09-03 Rsr有限公司 用作拮抗剂的抗促甲状腺激素受体的人单克隆抗体
ES2550158T3 (es) 2007-08-06 2015-11-04 Chugai Seiyaku Kabushiki Kaisha Método para medir la actividad inhibidora sobre la unión ligando-receptor
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations
CN110579593A (zh) * 2019-09-17 2019-12-17 郑州安图生物工程股份有限公司 一种刺激性促甲状腺激素受体抗体浓度的检测试剂盒
WO2026028159A1 (en) 2024-07-31 2026-02-05 Biohaven Therapeutics Ltd. Bifunctional degraders for the treatment of graves' disease

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
US4472508A (en) * 1982-12-30 1984-09-18 The Beth Israel Hospital Association Test for detecting and measuring the graves' disease-specific immunoglobulins
US4609622A (en) * 1983-05-31 1986-09-02 Interthyr Research Foundation Inc. Clinical determination and/or quantification of thyrotropin and a variety of thyroid stimulatory or inhibitory factors performed in vitro with an improved thyroid cell line, FRTL-5
EP0453482A4 (en) * 1989-01-11 1992-07-22 Us Health Biologically active synthetic thyrotropin and cloned gene for producing same
EP0614975B1 (de) 1989-05-05 2002-07-24 Genentech, Inc. Glykoprotein-Hormonrezeptor-Moleküle
US6261800B1 (en) * 1989-05-05 2001-07-17 Genentech, Inc. Luteinizing hormone/choriogonadotropin (LH/CG) receptor
US5614363A (en) * 1990-01-25 1997-03-25 New England Medical Center Hospitals, Inc. TSH receptor
US5744348A (en) * 1989-09-08 1998-04-28 New England Medical Center Hospitals, Inc. TSH receptor
US5578496A (en) * 1991-12-19 1996-11-26 Board Of Regents, Baylor College Of Medicine Detection of autoantibodies associated with the disease myasthenia gravis
US5705400A (en) * 1992-03-07 1998-01-06 Rsr Limited Assay for adrenal autoantigen
US5195860A (en) 1992-07-20 1993-03-23 Trw Inc. Push-on type fastener for automatic feed and installation equipment
WO1994018566A1 (fr) * 1993-02-04 1994-08-18 Sumitomo Pharmaceuticals Company, Limited Procede de dosage d'un anticorps specifique
DE4328070C1 (de) * 1993-08-20 1994-11-24 Henning Berlin Gmbh Verfahren zur Bestimmung eines Analyten in einem Volumen einer flüssigen Probe sowie seine Anwendung zur Bestimmung von anti-TSH-Rezeptor-Autoantikörpern in einem Patientenserum
EP0719858A3 (de) * 1994-12-27 1997-12-29 Tosoh Corporation Myeloma Zell-Linie die den rekombinanten menschlichen Rezeptor für das thyroid-stimulierenden Hormon exprimiert
DE19505266C1 (de) * 1995-02-16 1996-10-02 Brahms Diagnostica Gmbh Verwendung von polyklonalen humanen anti-hTg-Autoantikörpern als Reagenz für die klinische Diagnostik von Schilddrüsen-Autoimmunerkrankungen sowie Reagenziensatz für eine Bestimmung von anti-hTg-Autoantikörpern in Patientenseren
DE19522171C1 (de) 1995-06-19 1996-08-22 Brahms Diagnostica Gmbh Verfahren zur Bestimmung von Anti-TSH-Rezeptor-Autoantikörpern
US5723343A (en) * 1995-08-28 1998-03-03 University Of Florida Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
DE19728991A1 (de) * 1996-11-06 1999-02-11 Brahms Diagnostica Gmbh Rezeptorbindungsassay, für den Rezeptorbindungsassay geeigneter rekombinanter Fusionsrezeptor, Vektor zu dessen Herstellung sowie Reagenziensatz für die Durchführung des Rezeptorbindungsassays
DE19651093C2 (de) 1996-12-09 1999-06-10 Brahms Diagnostica Gmbh Rezeptorbindungsassay zum Nachweis von TSH-Rezeptor-Autoantikörpern sowie Reagenziensatz für die Durchführung eines solchen Rezeptorbindungsassays
ES2248133T3 (es) * 1999-10-12 2006-03-16 Ulrich Loos Procedimiento para la determinacion de autoanticuerpos contra el receptor de tsh.

Also Published As

Publication number Publication date
JP4331403B2 (ja) 2009-09-16
US6844162B1 (en) 2005-01-18
DE69932699D1 (en) 2006-09-21
GB9909661D0 (en) 1999-06-23
DE69932699T2 (de) 2007-08-09
WO1999064865A1 (en) 1999-12-16
EP1021721A1 (de) 2000-07-26
JP2002517757A (ja) 2002-06-18
EP1021721B1 (de) 2006-08-09
ES2270601T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
EP0232816A3 (en) Heterogeneous specific binding assay employing an aggregatable binding reagent
ATE226729T1 (de) Quantitative immunochromatographische assays
Johannsson Heterogeneous enzyme immunoassay
ATE221997T1 (de) Immunoassays zum nachweis von antiphospholipid- antikörpern
DE602004024236D1 (en) Assay
EP1072887A3 (de) Immunoassay
EP1418430A3 (de) Homogenes Testverfahren zur Bestimmung eines Analyten
AU2044795A (en) Reagents for specific binding assays
NO903124D0 (no) Testmetode og reagenssett for denne.
EP0125118A3 (en) Colorimetric immunoassay on solid surface, dipstick thercolorimetric immunoassay on solid surface, dipstick therefor and its preparation efor and its preparation
MXPA05005288A (es) Inmunoanalisis no competitivo para analitos pequenos.
Toivonen et al. Two-site time-resolved immunofluorometric assay of human insulin.
ATE336002T1 (de) Assays für tsh-rezeptor-autoantikörper
AU3059499A (en) Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
CA2157062A1 (en) Chemiluminescent reagent and assay using a substituted acetanilide for light generation
EP0902286A3 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
GB9823397D0 (en) Assays for thyroid autoantibodies
DE59903720D1 (de) Rezeptorbindungsassays und reagenziensatz zum nachweis von tsh-rezeptor-autoantikörpern
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
ES479985A1 (es) Un metodo mejorado para la deteccion y determinacion de un -acido biliar.
ES8802076A1 (es) Un procedimiento para efectuar un ensayo de fijacion especifica ligada a un marcador.
EP0368208A3 (de) Immunoassay-Verfahren und Testsatz dafür
CA2549066A1 (en) Diagnosing acute coronary syndrome by measuring levels of free papp-a
EP0757250A4 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
GB9813450D0 (en) Specific binding assays using methyl orange

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1021721

Country of ref document: EP